Radiation may buy time for liver cancer patients before stronger meds needed
NCT ID NCT06261047
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This study tested whether focused radiation can delay the need for stronger second-line drugs in people with liver cancer that has only a few new spots of growth (oligo progression). Thirty-six adults with advanced liver cancer received radiation to those spots. The goal was to see if this approach could extend the time before more intensive drug therapy is required, potentially improving quality of life and treatment control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jinbo Yue
Jinan, Shandong, 250000, China
Conditions
Explore the condition pages connected to this study.